Coverage
Breast cancer breakthroughs drive HCPs’ online conversations during ASCO 2025 - Oncology Today
oncologynewstoday.co.uk/breast-cancer-breakthroughs-drive-hcps-online-conversations-during-asco-2025/Breast cancer breakthroughs drive HCPs’ online conversations during ASCO 2025
pharmiweb.com/press-release/2025-06-13/breast-cancer-breakthroughs-drive-hcps-online-conversations-during-asco-2025Prostate cancer: HCPs discuss emerging treatments, artificial intelligence, and precision medicine on social media
pharmaphorum.com/oncology/prostate-cancer-hcps-discuss-emerging-treatments-artificial-intelligence-and-precisionNew platform allows pharma to tap into collective intelligence of millions of HCPs on social media in major therapy areas
pharmiweb.com/press-release/2025-03-11/new-platform-allows-pharma-to-tap-into-collective-intelligence-of-millions-of-hcps-on-social-media-in-major-therapy-areasCreation Healthcare Launches Platform to Analyze Global Social Media Discourse Among Healthcare Professionals
biopharmatrend.com/post/1268-creation-healthcare-launches-hcp-voice-platform-to-analyze-global-social-media-discourse-among-healthcare-professionals/BiopharmaTrend: Where Tech Meets Bio
Your go-to resource for news, trends, and analysis of the cutting-edge advances in pharma, biotech and healthcare. Stay informed with expert insights on technological developments shaping the industry.
Breast cancer oncologists use social media to engage with latest research, network with peers, and educate wider public, study finds - Oncology Today
oncologynewstoday.co.uk/breast-cancer-oncologists-use-social-media-to-engage-with-latest-research-network-with-peers-and-educate-wider-public-study-finds/Bluesky offers an opportunity pharma should not ignore
pharmaphorum.com/sales-marketing/bluesky-offers-opportunity-pharma-should-not-ignoreProstate cancer: HCPs discuss emerging therapies, clinical trials, imaging and AI diagnostics on social media
pharmiweb.com/press-release/2025-02-25/prostate-cancer-hcps-discuss-emerging-therapies-clinical-trials-imaging-and-ai-diagnostics-on-social-mediaProstate cancer: HCPs discuss emerging therapies, clinical trials, imaging and AI diagnostics on social media - Oncology Today
oncologynewstoday.co.uk/prostate-cancer-hcps-discuss-emerging-therapies-clinical-trials-imaging-and-ai-diagnostics-on-social-media/How do HCPs view the potential of AI in the pharmaceutical industry?
pharmaphorum.com/digital/how-do-hcps-view-potential-ai-pharmaceutical-industrySocial media advocacy: Healthcare professionals and the Treat and Reduce Obesity Act
pharmaphorum.com/patients/social-media-advocacy-healthcare-professionals-and-treat-and-reduce-obesity-actMarketing & PharmaSocial status: How pharma and health care marketing works on social media
marketingandpharma.com/social-status-how-pharma-and-health-care-marketing-works-on-social-media/Inside ESMO 2024: Treatments, trials, and top HCPs on social media
pharmaphorum.com/oncology/inside-esmo-2024-treatments-trials-and-top-hcps-social-mediaNarasimhan Replaces Bourla as Top Pharma CEO on Social Media
pharmaboardroom.com/articles/narasimhan-replaces-bourla-as-social-medias-top-pharma-ceo/PharmaBoardroom
PharmaBoardroom is a global platform that connects the experiences and expertise of C-level executives throughout the world. Covering management strategy, regulatory reforms, R&D, market access and pricing, PharmaBoardroom offers a seat at the table with pharma leaders and decision makers. We do this by providing unparalleled content that informs, engages and inspires senior professionals to help them understand global trends and strategies and translate them into local realities.
Clinicians discuss important sessions, colleague interactions on X during CHEST 2024
healio.com/news/pulmonology/20241018/clinicians-discuss-important-sessions-colleague-interactions-on-x-during-chest-2024Unpacking EASD 2024: Key themes, topics, and influencers
pharmaphorum.com/sales-marketing/unpacking-easd-2024-key-themes-topics-and-influencersClinicians talk COPD inhaler costs on X in first half of 2024
healio.com/news/pulmonology/20240918/clinicians-talk-copd-inhaler-costs-on-x-in-first-half-of-2024DOL Finder platform launch enables users to identify and monitor most influential digital healthcare professionals active in key disease spaces | Pharma Business International
pbiforum.net/mag/featured/dol-finder-platform-launch-enables-users-to-identify-and-monitor-most-influential-digital-healthcare-professionals-active-in-key-disease-spaces/HCP insights consultancy launches new platform for pharmaceutical industry to identify HCP sentiment and top digital opinion leaders in key disease sp
pharmiweb.com/press-release/2024-09-12/hcp-insights-consultancy-launches-new-platform-for-pharmaceutical-industry-to-identify-hcp-sentiment-and-top-digital-opinion-leaders-in-key-disease-spA New Tool to Spot Influential Healthcare Professionals in Pharma
biopharmatrend.com/post/945-a-new-tool-to-spot-influential-healthcare-professionals-in-pharma/BiopharmaTrend: Where Tech Meets Bio
Your go-to resource for news, trends, and analysis of the cutting-edge advances in pharma, biotech and healthcare. Stay informed with expert insights on technological developments shaping the industry.
Mixed reactions among HCPs as lecanemab and donanemab secure FDA approval for Alzheimer's treatment
pharmaphorum.com/digital/mixed-reactions-among-hcps-lecanemab-and-donanemab-secure-fda-approval-alzheimers-treatmentClinicians chat beta-blockers, dupilumab, ensifentrine for COPD on X in first half of 2024
healio.com/news/pulmonology/20240903/clinicians-chat-betablockers-dupilumab-ensifentrine-for-copd-on-x-in-first-half-of-2024Clinicians discuss COPD ventilation support, medications on X in first half of 2024
healio.com/news/pulmonology/20240812/clinicians-discuss-copd-ventilation-support-medications-on-x-in-first-half-of-2024HCPs 72 hours ahead of mainstream media in breaking news of shingle vaccine’s dementia effects
pharmiweb.com/article/hcps-72-hours-ahead-of-mainstream-media-in-breaking-news-of-shingle-vaccine-s-dementia-effectsDeepening perspectives: How social media is driving our understanding of HCP sentiment
pharmaphorum.com/market-access/deepening-perspectives-how-social-media-driving-our-understanding-hcp-sentimentGeneral election results - live: Starmer meeting King after landslide Labour win
independent.co.uk/news/uk/politics/general-election-results-uk-labour-starmer-tory-latest-b2574568.htmlTop cancer types, trials, and AI innovations: What HCPs discussed most at ASCO 2024
pharmaphorum.com/oncology/top-cancer-types-trials-and-ai-innovations-what-hcps-discussed-most-asco-2024Lung cancer dominates ASCO social media conversation among health care professionals
healio.com/news/hematology-oncology/20240618/lung-cancer-dominates-asco-social-media-conversation-among-health-care-professionalsOncologists pleased with new treatments for lymphoma, lung cancer, urothelial cancer
healio.com/news/hematology-oncology/20240614/oncologists-pleased-with-new-treatments-for-lymphoma-lung-cancer-urothelial-cancerHealthcare professionals hail ‘game-changing’ cancer vaccine trial - but some wary that vaccine hesitancy could hinder uptake
pharmiweb.com/article/healthcare-professionals-hail-game-changing-cancer-vaccine-trial-but-some-wary-that-vaccine-hesitancy-could-hinder-uptakeHealth care professionals celebrate ‘milestone’ FDA approval for HER2-positive solid tumors
healio.com/news/hematology-oncology/20240520/physicians-celebrate-milestone-fda-approval-for-her2positive-solid-tumorsHyde Park haze illustrates clear need for cannabis education
commentcentral.co.uk/hyde-park-haze-illustrates-clear-need-for-cannabis-educationHealth care professionals ‘thrilled’ with approval of first treatment for MASH
healio.com/news/gastroenterology/20240423/health-care-professionals-thrilled-with-approval-of-first-treatment-for-mashHealth care professionals enthusiastic about approval of first cell therapy for melanoma
healio.com/news/hematology-oncology/20240308/health-care-professionals-enthusiastic-about-approval-of-first-cell-therapy-for-melanomaPfizer and Novartis chiefs lead pharma's CEO influencers on social media, analysis finds
endpts.com/pfizer-and-novartis-chiefs-lead-pharmas-ceo-influencers-on-social-media-analysis-finds/Five leading digital opinion leaders in women’s health advocacy and excellence
healio.com/news/womens-health-ob-gyn/20240202/five-leading-digital-opinion-leaders-in-womens-health-advocacy-and-excellenceHealth professionals enthusiastic about approval of gene therapies for sickle cell disease
healio.com/news/hematology-oncology/20240116/health-professionals-enthusiastic-about-approval-of-gene-therapies-for-sickle-cell-diseaseStriking Doctors losing support as "perfect storm" hits hospital
Junior doctors’ strike: minority of public in favour as support wanes
thetimes.co.uk/article/133cf53a-705d-4561-b4af-26c6110d02e0?shareToken=485a131c3476c45c6c89ac3e73e0ab71Health care professionals optimistic as tirzepatide approved for obesity treatment
healio.com/news/endocrinology/20231220/health-care-professionals-optimistic-after-new-weightloss-drug-approvedHCPs welcome approval of updated Novavax COVID-19 vaccine
healio.com/news/primary-care/20231129/hcps-welcome-approval-of-updated-novavax-covid19-vaccineUpdated COVID-19 vaccines receive mixed support among health care professionals online
healio.com/news/infectious-disease/20231024/updated-covid19-vaccines-receive-mixed-support-among-health-care-professionals-onlineHealth care professionals express support for postpartum depression, myeloma treatments
healio.com/news/hematology-oncology/20230928/health-care-professionals-express-support-for-postpartum-depression-myeloma-treatmentsFirst nonprescription oral contraceptive sees strong support among providers
healio.com/news/womens-health-ob-gyn/20230907/first-nonprescription-contraceptive-sees-strong-support-among-providersPfizer’s Albert Bourla is Pharma’s Top Social Media Performer
pharmaboardroom.com/articles/pfizers-albert-bourla-is-pharmas-top-social-media-performer/PharmaBoardroom
PharmaBoardroom is a global platform that connects the experiences and expertise of C-level executives throughout the world. Covering management strategy, regulatory reforms, R&D, market access and pricing, PharmaBoardroom offers a seat at the table with pharma leaders and decision makers. We do this by providing unparalleled content that informs, engages and inspires senior professionals to help them understand global trends and strategies and translate them into local realities.